Mediclinic joins Abu Dhabi's Hub71+ Life Sciences to validate healthtech startups
What's the deal? Mediclinic Middle EastDealroom has a profile for this one. Try Dealroom → has joined Hub71+ Life Sciences, Abu Dhabi's specialist ecosystem for biotech, medtech and digital health. The private healthcare provider signed a memorandum of understanding with Hub71 at the Abu Dhabi Future Health Summit 2026, giving startups access to clinical expertise and real-world healthcare insights.
What's the endgame? Mediclinic will work with healthtech founders to refine their products and test them in clinical settings. It will also explore technologies tied to its own priorities, including cancer care, fertility and IVF, chronic disease management, women's health and virtual care.
Why it matters: The partnership aims to close the gap between early-stage technology and adoption in actual care — a persistent hurdle for healthtech startups.
"Startups have significant potential to transform healthcare when given access to the right industry partners and opportunities to validate and scale their solutions," said Basma AlBadi AlDhaheri, head of growth and value creation at Hub71.
Hein van Eck, chief executive officer of Mediclinic Middle East, framed the value in patient terms. "Innovation has an important role to play in shaping the future of healthcare, but its real value lies in how it improves the care we deliver to patients," he said.
The context: Hub71+ Life Sciences launched in 2025 with the Department of Health – Abu Dhabi, the Emirates Drug Establishment and the HELM cluster as founding partners. It connects startups with providers, regulators and investors. Mediclinic's arrival follows a September partnership with Unilabs Middle East, which already has startup collaborations underway.
The signal: Abu Dhabi is assembling clinical partners to build a pipeline from startup technology to deployment in care. For now, the Mediclinic deal is a framework for mentorship and potential collaboration; its payoff will depend on whether it produces pilots, validation or adoption rather than an ecosystem affiliation alone.
Read more: healthcaremea.com
Image credit: Generated with Gemini
